Table 1.
Target | Scheme/Figure | P-S Carbonyl Partner and Catalyst | Note | [Ref] |
---|---|---|---|---|
(±)-cribrostatin 4 (±)-renieramycin G |
Scheme 20 Figure 3 |
(EtO)2CHCH2OBz TMSOTf |
cytotoxic studies | [82,83,84,85] |
(±)-hamayne | Figure 3 | CH2O/HCO2H | crinine type alkaloids | [86] |
(±)-lycorane | Figure 3 | CH2O/HCl | Amaryllidaceae family | [87] |
(−)-saframycin A | Scheme 21 | OHC-CH2NHCbz CF3CH2OH, AcOH, 4 Å MS |
intermolecular P-S (C-1) intramolecular P-S (C-11) |
[88] |
mitragynine, paynantheine, speciogynine | Scheme 22 | Aldehyde 80 Thiourea-derived catalysts |
Mitragyna yohimbinoid alkaloids | [89] |
(±)-tangutorine | Scheme 23 | Aldehyde 83 micRowave |
the same cytotoxic activity for racemate and pure enantiomers | [90] |
(−)-lemonomycin | Figure 3 | Cinnamaldehyde CSA, TMSCN |
potent activity against drug-resistant cocci | [91] |
tetracyclic core of lemonomycin | Figure 3 | OHC-CO2Et CF3CH2OH, AcOH, 4 Å MS |
substrate-induced stereocontrol strategy | [92] |
venenatine alstovenine |
Scheme 24 | Compound 86 HCl (aq) oR DMAP oR NaI |
yohimbinoid alkaloids C-3 stereochemistry |
[93] |
3-arylacrilamide (C-1)-side chain derivatives | Figure 3 | OHC-CH2NHCbz NaOAc/AcOH |
saframycin/ecteinascidin type compounds | [94,95] |
(+)-lochnerine (+)-dispegatrine |
Figure 3 | OHC(CH2)2CO2Me AcOH |
sarpagine type | [96] |
(−)-jorunnamycins A, C (−)-jorumycin |
Scheme 26 | Compound 89 CF3CH2OH, AcOH |
renieramycin type | [97] |
(−)-renieramycin G | Scheme 26 | Compound 89 CF3CH2OH, AcOH |
renieramycin type | [98] |
(±)-alstonerine | Scheme 25 | Compound 91 Wet CH2Cl2 |
macroline/sarpagine type | [99] |
erysotramidine | Scheme 25 | Compound 93 H3PO4 |
erythrina alkaloids | [100,101] |
(±)-actinophyllic acid | Scheme 27 | Different form of P-S | indolohydroazocine | [102] |
cribrostatin 4 renieramycin I |
Scheme 28 | (EtO)2CHCH2OBz TMSOTf/Ac2O | synthesis of left-half renieramycin model compound | [103,104] |
(+)-yohimbine | Figure 3 | Reported in [65] | - | [105] |
(−)-corynantheidine | Figure 3 | Reported in [65] | corynanthe alkaloids | [106] |
(−)-corynantheine (−)-dihydrocorynantheine |
Figure 3 | Reported in [65] | corynanthe alkaloids | [107] |
(−)-affinisine oxindole | Figure 3 | Reported in [66] | - | [108] |